Is Celestica The Best AI Stock to Buy Now?
Technology and hardware business Celestica (NYSE:CLS) has seen massive upward…
Sell
44
GTHP Quote, Financials, Valuation and Earnings
Last price:
$0.37
Seasonality move
:
-8.93%
Day range:
$0.37 - $0.37
52-week range:
$0.06 - $0.54
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
150.88x
P/B ratio:
--
Volume:
401
Avg. volume:
8.1K
1-year change:
230.06%
Market cap:
$30.9M
Revenue:
$7K
EPS (TTM):
-$0.04
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
GTHP
Guided Therapeutics, Inc.
|
-- | -- | -- | -- | -- |
|
CNMD
CONMED Corp.
|
$366.9M | $1.32 | -2.76% | 322.31% | $47.40 |
|
ELMD
Electromed, Inc.
|
$18M | -- | 11.79% | -- | $37.00 |
|
ESMC
Escalon Medical Corp.
|
-- | -- | -- | -- | -- |
|
IRIX
IRIDEX Corp.
|
$14.7M | -$0.02 | 10.68% | -50.4% | $3.00 |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
GTHP
Guided Therapeutics, Inc.
|
$0.37 | -- | $30.9M | -- | $0.00 | 0% | 150.88x |
|
CNMD
CONMED Corp.
|
$46.00 | $47.40 | $1.4B | 30.36x | $0.20 | 1.74% | 1.04x |
|
ELMD
Electromed, Inc.
|
$24.07 | $37.00 | $199.2M | 23.43x | $0.00 | 0% | 3.06x |
|
ESMC
Escalon Medical Corp.
|
$0.24 | -- | $1.8M | 154.45x | $0.00 | 0% | 0.21x |
|
IRIX
IRIDEX Corp.
|
$1.46 | $3.00 | $25.1M | -- | $0.00 | 0% | 0.48x |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
GTHP
Guided Therapeutics, Inc.
|
-74.91% | 3.813 | 11.94% | 0.01x |
|
CNMD
CONMED Corp.
|
46.21% | 0.814 | 70.58% | 0.94x |
|
ELMD
Electromed, Inc.
|
-- | 0.920 | -- | 4.40x |
|
ESMC
Escalon Medical Corp.
|
31.63% | 2.696 | 43.39% | 1.03x |
|
IRIX
IRIDEX Corp.
|
50.55% | 0.622 | 18.81% | 1.03x |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
GTHP
Guided Therapeutics, Inc.
|
$8K | -$485K | -- | -- | -808.33% | -$279K |
|
CNMD
CONMED Corp.
|
$213.3M | $66.9M | 2.49% | 4.72% | 17.91% | $41.2M |
|
ELMD
Electromed, Inc.
|
$14.8M | $3.6M | 20.33% | 20.35% | 19.16% | $2.4M |
|
ESMC
Escalon Medical Corp.
|
$1.6M | $98.7K | -10.13% | -12.94% | 2.75% | -$517.4K |
|
IRIX
IRIDEX Corp.
|
$4M | -$1.4M | -54.1% | -155.93% | -11.3% | -$1.2M |
Guided Therapeutics, Inc. vs. Competitors
-
Which has Higher Returns GTHP or CNMD?
CONMED Corp. has a net margin of -1236.67% compared to Guided Therapeutics, Inc.'s net margin of 4.48%. Guided Therapeutics, Inc.'s return on equity of -- beat CONMED Corp.'s return on equity of 4.72%.
Company Gross Margin Earnings Per Share Invested Capital GTHPGuided Therapeutics, Inc.13.33% -$0.01 -$3.2M CNMDCONMED Corp.57.12% $0.54 $1.9B -
What do Analysts Say About GTHP or CNMD?
Guided Therapeutics, Inc. has a consensus price target of --, signalling upside risk potential of 30270170.27%. On the other hand CONMED Corp. has an analysts' consensus of $47.40 which suggests that it could grow by 3.04%. Given that Guided Therapeutics, Inc. has higher upside potential than CONMED Corp., analysts believe Guided Therapeutics, Inc. is more attractive than CONMED Corp..
Company Buy Ratings Hold Ratings Sell Ratings GTHPGuided Therapeutics, Inc.0 0 0 CNMDCONMED Corp.0 5 0 -
Is GTHP or CNMD More Risky?
Guided Therapeutics, Inc. has a beta of 0.606, which suggesting that the stock is 39.441% less volatile than S&P 500. In comparison CONMED Corp. has a beta of 0.967, suggesting its less volatile than the S&P 500 by 3.283%.
-
Which is a Better Dividend Stock GTHP or CNMD?
Guided Therapeutics, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. CONMED Corp. offers a yield of 1.74% to investors and pays a quarterly dividend of $0.20 per share. Guided Therapeutics, Inc. pays -- of its earnings as a dividend. CONMED Corp. pays out 18.82% of its earnings as a dividend. CONMED Corp.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios GTHP or CNMD?
Guided Therapeutics, Inc. quarterly revenues are $60K, which are smaller than CONMED Corp. quarterly revenues of $373.5M. Guided Therapeutics, Inc.'s net income of -$742K is lower than CONMED Corp.'s net income of $16.7M. Notably, Guided Therapeutics, Inc.'s price-to-earnings ratio is -- while CONMED Corp.'s PE ratio is 30.36x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Guided Therapeutics, Inc. is 150.88x versus 1.04x for CONMED Corp.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income GTHPGuided Therapeutics, Inc.150.88x -- $60K -$742K CNMDCONMED Corp.1.04x 30.36x $373.5M $16.7M
-
Which has Higher Returns GTHP or ELMD?
Electromed, Inc. has a net margin of -1236.67% compared to Guided Therapeutics, Inc.'s net margin of 14.61%. Guided Therapeutics, Inc.'s return on equity of -- beat Electromed, Inc.'s return on equity of 20.35%.
Company Gross Margin Earnings Per Share Invested Capital GTHPGuided Therapeutics, Inc.13.33% -$0.01 -$3.2M ELMDElectromed, Inc.78.42% $0.32 $45.4M -
What do Analysts Say About GTHP or ELMD?
Guided Therapeutics, Inc. has a consensus price target of --, signalling upside risk potential of 30270170.27%. On the other hand Electromed, Inc. has an analysts' consensus of $37.00 which suggests that it could grow by 53.72%. Given that Guided Therapeutics, Inc. has higher upside potential than Electromed, Inc., analysts believe Guided Therapeutics, Inc. is more attractive than Electromed, Inc..
Company Buy Ratings Hold Ratings Sell Ratings GTHPGuided Therapeutics, Inc.0 0 0 ELMDElectromed, Inc.3 0 0 -
Is GTHP or ELMD More Risky?
Guided Therapeutics, Inc. has a beta of 0.606, which suggesting that the stock is 39.441% less volatile than S&P 500. In comparison Electromed, Inc. has a beta of 0.264, suggesting its less volatile than the S&P 500 by 73.581%.
-
Which is a Better Dividend Stock GTHP or ELMD?
Guided Therapeutics, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Electromed, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Guided Therapeutics, Inc. pays -- of its earnings as a dividend. Electromed, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios GTHP or ELMD?
Guided Therapeutics, Inc. quarterly revenues are $60K, which are smaller than Electromed, Inc. quarterly revenues of $18.9M. Guided Therapeutics, Inc.'s net income of -$742K is lower than Electromed, Inc.'s net income of $2.8M. Notably, Guided Therapeutics, Inc.'s price-to-earnings ratio is -- while Electromed, Inc.'s PE ratio is 23.43x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Guided Therapeutics, Inc. is 150.88x versus 3.06x for Electromed, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income GTHPGuided Therapeutics, Inc.150.88x -- $60K -$742K ELMDElectromed, Inc.3.06x 23.43x $18.9M $2.8M
-
Which has Higher Returns GTHP or ESMC?
Escalon Medical Corp. has a net margin of -1236.67% compared to Guided Therapeutics, Inc.'s net margin of 2.72%. Guided Therapeutics, Inc.'s return on equity of -- beat Escalon Medical Corp.'s return on equity of -12.94%.
Company Gross Margin Earnings Per Share Invested Capital GTHPGuided Therapeutics, Inc.13.33% -$0.01 -$3.2M ESMCEscalon Medical Corp.43.33% $0.01 $2.6M -
What do Analysts Say About GTHP or ESMC?
Guided Therapeutics, Inc. has a consensus price target of --, signalling upside risk potential of 30270170.27%. On the other hand Escalon Medical Corp. has an analysts' consensus of -- which suggests that it could grow by 4900%. Given that Guided Therapeutics, Inc. has higher upside potential than Escalon Medical Corp., analysts believe Guided Therapeutics, Inc. is more attractive than Escalon Medical Corp..
Company Buy Ratings Hold Ratings Sell Ratings GTHPGuided Therapeutics, Inc.0 0 0 ESMCEscalon Medical Corp.0 0 0 -
Is GTHP or ESMC More Risky?
Guided Therapeutics, Inc. has a beta of 0.606, which suggesting that the stock is 39.441% less volatile than S&P 500. In comparison Escalon Medical Corp. has a beta of 0.389, suggesting its less volatile than the S&P 500 by 61.1%.
-
Which is a Better Dividend Stock GTHP or ESMC?
Guided Therapeutics, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Escalon Medical Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Guided Therapeutics, Inc. pays -- of its earnings as a dividend. Escalon Medical Corp. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios GTHP or ESMC?
Guided Therapeutics, Inc. quarterly revenues are $60K, which are smaller than Escalon Medical Corp. quarterly revenues of $3.6M. Guided Therapeutics, Inc.'s net income of -$742K is lower than Escalon Medical Corp.'s net income of $97.7K. Notably, Guided Therapeutics, Inc.'s price-to-earnings ratio is -- while Escalon Medical Corp.'s PE ratio is 154.45x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Guided Therapeutics, Inc. is 150.88x versus 0.21x for Escalon Medical Corp.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income GTHPGuided Therapeutics, Inc.150.88x -- $60K -$742K ESMCEscalon Medical Corp.0.21x 154.45x $3.6M $97.7K
-
Which has Higher Returns GTHP or IRIX?
IRIDEX Corp. has a net margin of -1236.67% compared to Guided Therapeutics, Inc.'s net margin of -12.6%. Guided Therapeutics, Inc.'s return on equity of -- beat IRIDEX Corp.'s return on equity of -155.93%.
Company Gross Margin Earnings Per Share Invested Capital GTHPGuided Therapeutics, Inc.13.33% -$0.01 -$3.2M IRIXIRIDEX Corp.32.15% -$0.09 $9.5M -
What do Analysts Say About GTHP or IRIX?
Guided Therapeutics, Inc. has a consensus price target of --, signalling upside risk potential of 30270170.27%. On the other hand IRIDEX Corp. has an analysts' consensus of $3.00 which suggests that it could grow by 105.48%. Given that Guided Therapeutics, Inc. has higher upside potential than IRIDEX Corp., analysts believe Guided Therapeutics, Inc. is more attractive than IRIDEX Corp..
Company Buy Ratings Hold Ratings Sell Ratings GTHPGuided Therapeutics, Inc.0 0 0 IRIXIRIDEX Corp.1 0 0 -
Is GTHP or IRIX More Risky?
Guided Therapeutics, Inc. has a beta of 0.606, which suggesting that the stock is 39.441% less volatile than S&P 500. In comparison IRIDEX Corp. has a beta of 0.705, suggesting its less volatile than the S&P 500 by 29.514%.
-
Which is a Better Dividend Stock GTHP or IRIX?
Guided Therapeutics, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. IRIDEX Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Guided Therapeutics, Inc. pays -- of its earnings as a dividend. IRIDEX Corp. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios GTHP or IRIX?
Guided Therapeutics, Inc. quarterly revenues are $60K, which are smaller than IRIDEX Corp. quarterly revenues of $12.5M. Guided Therapeutics, Inc.'s net income of -$742K is higher than IRIDEX Corp.'s net income of -$1.6M. Notably, Guided Therapeutics, Inc.'s price-to-earnings ratio is -- while IRIDEX Corp.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Guided Therapeutics, Inc. is 150.88x versus 0.48x for IRIDEX Corp.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income GTHPGuided Therapeutics, Inc.150.88x -- $60K -$742K IRIXIRIDEX Corp.0.48x -- $12.5M -$1.6M
Related Companies
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will AI Disrupt SaaS Software Stocks?
Since January 28th, software stocks in the United States have…
Why Is Meta Stock Going Higher?
Over the last five days, shares of Instagram and Facebook…
Stock Ideas
Sell
50
Is NVDA Stock a Buy?
Market Cap: $4.5T
P/E Ratio: 38x
Sell
48
Is AAPL Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 35x
Sell
37
Is GOOGL Stock a Buy?
Market Cap: $3.7T
P/E Ratio: 28x
Alerts
Buy
59
SEZL alert for Feb 27
Sezzle, Inc. [SEZL] is down 13.92% over the past day.
Buy
83
GCT alert for Feb 28
GigaCloud Technology, Inc. [GCT] is down 5.87% over the past day.
Buy
62
LMAT alert for Feb 27
LeMaitre Vascular, Inc. [LMAT] is down 4.76% over the past day.
